Vincent Lévy

9.0k total citations
189 papers, 5.3k citations indexed

About

Vincent Lévy is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Vincent Lévy has authored 189 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Genetics, 40 papers in Pathology and Forensic Medicine and 36 papers in Oncology. Recurrent topics in Vincent Lévy's work include Chronic Lymphocytic Leukemia Research (62 papers), Lymphoma Diagnosis and Treatment (36 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Vincent Lévy is often cited by papers focused on Chronic Lymphocytic Leukemia Research (62 papers), Lymphoma Diagnosis and Treatment (36 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Vincent Lévy collaborates with scholars based in France, United States and Belgium. Vincent Lévy's co-authors include Laurent Zelek, Éléna Paillaud, Frédéric Pamoukdjian, Marouane Boubaya, Sylvie Chevret, Michaël Soussan, T. Bouillet, Raphaël Porcher, Sandrine Katsahian and Élie Azoulay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Vincent Lévy

180 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Lévy France 42 1.4k 1.3k 1.3k 1000 829 189 5.3k
Alexandre E. Voskuyl Netherlands 50 713 0.5× 777 0.6× 1.6k 1.3× 800 0.8× 1.2k 1.4× 246 9.2k
Eisuke Inoue Japan 39 658 0.5× 509 0.4× 791 0.6× 391 0.4× 782 0.9× 233 5.5k
Carlomaurizio Montecucco Italy 54 1.0k 0.7× 799 0.6× 1.4k 1.1× 950 0.9× 1.9k 2.3× 436 9.9k
Gerlinde Egerer Germany 41 725 0.5× 1.4k 1.1× 887 0.7× 927 0.9× 1.2k 1.5× 181 4.6k
Andrew Artz United States 40 874 0.6× 1.7k 1.3× 373 0.3× 783 0.8× 2.9k 3.5× 221 6.2k
Mark A. Weiss United States 33 620 0.4× 1.0k 0.8× 668 0.5× 661 0.7× 839 1.0× 148 5.1k
Enric Carreras Spain 52 1.4k 1.0× 2.2k 1.7× 858 0.7× 1.1k 1.1× 5.1k 6.2× 255 8.4k
Jai Radhakrishnan United States 49 515 0.4× 846 0.7× 849 0.7× 701 0.7× 565 0.7× 191 9.1k
Michael B. Stokes United States 42 532 0.4× 922 0.7× 771 0.6× 355 0.4× 642 0.8× 106 6.1k
Eleftherios C. Vamvakas United States 42 521 0.4× 587 0.5× 1.1k 0.8× 808 0.8× 1.5k 1.8× 113 6.2k

Countries citing papers authored by Vincent Lévy

Since Specialization
Citations

This map shows the geographic impact of Vincent Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Lévy more than expected).

Fields of papers citing papers by Vincent Lévy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Lévy. The network helps show where Vincent Lévy may publish in the future.

Co-authorship network of co-authors of Vincent Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Lévy. A scholar is included among the top collaborators of Vincent Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Lévy. Vincent Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Campani, Claudia, Jules Grégory, François Durand, et al.. (2023). Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022). JHEP Reports. 5(7). 100755–100755. 2 indexed citations
3.
Vimeux, Lene, Vincent Contremoulins, Florence Cymbalista, et al.. (2022). Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21. Blood Advances. 6(16). 4691–4704. 13 indexed citations
4.
Errera, Marie‐Hélène, Sylvain Fisson, Marouane Boubaya, et al.. (2022). Cytokines, chemokines and growth factors profile in human aqueous humor in idiopathic uveitis. PLoS ONE. 17(1). e0254972–e0254972. 25 indexed citations
5.
Lévy, Vincent, Arnaud Millet, Monika E. Dolega, et al.. (2020). Measuring cell displacements in opaque tissues: dynamic light scattering in the multiple scattering regime. Biomedical Optics Express. 11(4). 2277–2277. 2 indexed citations
6.
Quinquenel, Anne, Luc‐Matthieu Fornecker, Rémi Letestu, et al.. (2019). Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study. Blood. 134(7). 641–644. 88 indexed citations
7.
Viallard, Jean‐François, Sylvain Choquet, Bruno Royer, et al.. (2018). The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments. Hematology. 24(1). 173–182. 19 indexed citations
8.
Lévy, Vincent, et al.. (2018). Ethnical differences in normal retinal capillary density and foveal avascular zone measurements. Investigative Ophthalmology & Visual Science. 59(9). 2859–2859. 1 indexed citations
9.
Lévy, Vincent. (2017). Le bail réel solidaire: une petite révolution du droit de propriété à mettre en perspective. 137(5). 3065–3068.
10.
Leleu, Xavier, Jérôme Tamburini, Aldo M. Roccaro, et al.. (2009). Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue–Based Therapy. Clinical Lymphoma & Myeloma. 9(1). 71–73. 20 indexed citations
11.
Bergeron, Anne, Delphine Réa, Vincent Lévy, et al.. (2007). Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia. American Journal of Respiratory and Critical Care Medicine. 176(8). 814–818. 116 indexed citations
12.
Lévy, Vincent. (2006). Enforcing International Norms in the United States After Roper v. Simmons: The Case of Juvenile Offenders Sentenced to Life Without Parole. Columbia journal of transnational law. 45(1). 262–311. 1 indexed citations
13.
Hunault, Mathilde, Aline Schmidt, Vincent Lévy, et al.. (2005). rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study. Bone Marrow Transplantation. 35(9). 903–907. 4 indexed citations
14.
Lévy, Vincent, Alain Delmer, & Florence Ajchenbaum‐Cymbalista. (2000). Facteurs pronostiques de la leucémie lymphoïde chronique. Hématologie. 6(3). 219–225. 1 indexed citations
15.
Biour, M, J.–M. Davy, Thierry Poynard, & Vincent Lévy. (1990). [Is fluindione hepatotoxic?].. PubMed. 14(10). 782–782. 4 indexed citations
16.
Biour, M, R. Poupon, Jean‐Daniel Grange, et al.. (1988). Hépatotoxicité des médicaments. Mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables.. Gastroentérologie Clinique et Biologique. 12(1). 64–88. 12 indexed citations
17.
Gauthier, A., Vincent Lévy, A Quinton, et al.. (1986). Salt or no salt in the treatment of cirrhotic ascites: a randomised study.. Gut. 27(6). 705–709. 44 indexed citations
18.
Grippon, P., et al.. (1985). Angiomyolipome du foie. Une découverte échographique fortuite.. Gastroentérologie Clinique et Biologique. 9(1). 88–89. 4 indexed citations
19.
Lévy, Vincent, et al.. (1979). Valve péritonéo-jugulaire pour ascite irréductible. Bilan de 23 malades.. Gastroentérologie Clinique et Biologique. 3(5). 1 indexed citations
20.
Delchier, J.C., Jean‐Michel Métreau, Vincent Lévy, P Opolon, & Daniel Dhumeaux. (1979). [Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)].. PubMed. 8(37). 2955–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandre E. Voskuyl Breakdown of academic impact, for papers by Eisuke Inoue Breakdown of academic impact, for papers by Carlomaurizio Montecucco Breakdown of academic impact, for papers by Gerlinde Egerer Breakdown of academic impact, for papers by Andrew Artz Breakdown of academic impact, for papers by Mark A. Weiss Breakdown of academic impact, for papers by Enric Carreras Breakdown of academic impact, for papers by Jai Radhakrishnan Breakdown of academic impact, for papers by Michael B. Stokes Breakdown of academic impact, for papers by Eleftherios C. Vamvakas
Rankless by CCL
2026